share_log

Cassava Sciences | 8-A12B: Registration of a class of securities on a national securities exchange

SEC announcement ·  Jan 3 00:00
Summary by Moomoo AI
Cassava Sciences, Inc., a biotechnology company based in Austin, Texas, has announced the registration of warrants for purchase of its common stock with the United States Securities and Exchange Commission (SEC). These warrants, expiring on or before November 15, 2024, will be distributed to shareholders of record as of December 22, 2023. The distribution of the warrants is set to occur on or about January 3, 2023. Each warrant entitles the holder to purchase shares of Cassava Sciences' common stock at a price of $33.00, along with an additional 0.5 share per warrant exercised before the Bonus Share Expiration Date. The company has applied to list these warrants on The Nasdaq Capital Market under the symbol 'SAVAW'. Cassava Sciences has also outlined the conditions under which the warrants...Show More
Cassava Sciences, Inc., a biotechnology company based in Austin, Texas, has announced the registration of warrants for purchase of its common stock with the United States Securities and Exchange Commission (SEC). These warrants, expiring on or before November 15, 2024, will be distributed to shareholders of record as of December 22, 2023. The distribution of the warrants is set to occur on or about January 3, 2023. Each warrant entitles the holder to purchase shares of Cassava Sciences' common stock at a price of $33.00, along with an additional 0.5 share per warrant exercised before the Bonus Share Expiration Date. The company has applied to list these warrants on The Nasdaq Capital Market under the symbol 'SAVAW'. Cassava Sciences has also outlined the conditions under which the warrants can be redeemed and the adjustments applicable to the Basic Warrant Exercise Rate and the Bonus Share Expiration Trigger Price. The company will provide public notice prior to any redemption or expiration event related to the warrants. The distribution of the warrants is part of a dividend issuance and has not been registered under the Securities Act, with the company planning to file a prospectus supplement for the shares of common stock underlying the warrants.

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more